Physician profile
Morgan Johnson
NPI 1508098740
$2,121.42
in general payments reported to CMS, 2019-2025
10 companies · $860 in 2025
The $860 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $306 · 2022: $193 · 2023: $371 · 2024: $391 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466 · Consulting Fee: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.97 |
| Consulting Fee | $156.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,211.23 | 2022-2025 | Watchman Flx, Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.93 | 2021-2025 | Jardiance |
| Abbott Laboratories | $156.25 | 2025 | Cardiomems |
| Amgen INC. | $129.70 | 2021-2025 | Repatha |
| Esperion Therapeutics, INC. | $116.09 | 2021 | |
| Abiomed | $47.47 | 2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $41.64 | 2023-2024 | Eliquis |
| Regeneron Healthcare Solutions, INC. | $30.74 | 2025 | Dupixent |
| Azurity Pharmaceuticals, INC. | $24.56 | 2025 | Zonisade |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.